Sai Life Sciences

Hyderabad, India
Small Molecule API Complex Small Molecules HPAPI ADC Peptides Oligonucleotides Lipids / LNP Intermediates Drug Discovery (CRO)
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (10) ○ EMA GMP ○ MHRA GMP

Quick Facts: Sai Life Sciences

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Hyderabad, India
Modalities
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Sai Life Sciences

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs no verified data
Sponsorsno verified data
ModalitiesSmall Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (9 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (9 modalities)

Recent News 10 articles

news Wed, 25 Fe
Sai Life Sciences plans to recruit 700+ professionals in FY27 as Indian CRDMO demand accelerates - drugdiscoverytrends.com
news Wed, 05 No
Sai Life Sciences doubles CMC process R&D capacity in Hyderabad - drugdiscoverytrends.com
news Tue, 09 Ju
Sai Life Sciences sees strong growth runway as global pharma shifts sourcing beyond China - CNBC TV18
news Thu, 25 Ju
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life Sciences - The Economic Times
news Thu, 21 Ma
Sai Life Sciences Files Q4FY26 Earnings Call Transcript - scanx.trade
news Thu, 18 Se
Sai Life Sciences veterinary API expansion in India - drugdiscoverytrends.com
news Sat, 16 Ma
4 CDMO Stocks with Strong Growth Plans - Equitymaster
news Mon, 11 Au
Sai Life Sciences: Strong start keeps CDMO business in the lead - Moneycontrol.com
news Mon, 05 Ja
Sai Life rallies 5%, hits all-time high; what's driving pharma stock? - Business Standard
news Fri, 08 Ma
Laurus, Sai Life Sciences up 3% in weak market; what's driving CDMO stocks? - Business Standard

Frequently Asked Questions About Sai Life Sciences

What is Sai Life Sciences's CDMO Signal Score?
Sai Life Sciences has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Sai Life Sciences for a manufacturing program?
Use the free AI matchmaker to compare Sai Life Sciences against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
HPAPI CDMOs → ADC CDMOs → Oligonucleotides CDMOs → Lipids / LNP CDMOs →

Similar CDMOs

PCI Pharma Services
Philadelphia, PA
Sterile fill-finish, Prefilled syringes, Cartridges, Vials, Lyophilization, ADC fill-finish, HPAPI, mRNA, Biologics, Oligonucleotides, Peptides
Abzena
Raleigh, NC
ADC, AOC, RDC, Biologics, mAb, HPAPI, Bioconjugation
Fermion (Orion Group)
Espoo, Finland
Small Molecule API, HPAPI, Semi-solid drug product (creams, gels, ointments), Hormonal products
Sterling Pharma Solutions
Cramlington, United Kingdom
ADC, Bioconjugation, HPAPI/Small Molecule API, Peptides, Linker-Payload Synthesis
Veranova
Devens, MA (US HQ); multiple global sites
Small Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide